v3.25.2
Statement of Changes in Stockholders' Equity - USD ($)
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2023 $ 5 $ 117 $ 145,946,257 $ (131,080,749) $ 14,865,630
Balance (in shares) at Jun. 30, 2023 547,674 11,698,497      
Proceeds from sale of common stock in connection with equity financings net of issuance costs   $ 13 3,120,024   3,120,037
Proceeds from sale of common stock in connection with equity financings net of issuance costs (in shares)   1,308,651      
Series A preferred stock issued for employee stock compensation     43,245   43,245
Series A preferred stock issued for employee stock compensation (in shares) 13,092        
Series A preferred stock issued upon conversion of related party promissory note $ 4   1,499,996   1,500,000
Series A preferred stock issued upon conversion of related party promissory note (in shares) 331,859        
Common stock issued for consulting and legal services rendered   $ 1 131,599   131,600
Common stock issued for consulting and legal services rendered (in shares)   101,542      
Warrants issued to Scientific Advisory Board     563   563
Common stock issued for employee compensation     2,340   2,340
Common stock issued for employee compensation (in shares)   1,786      
Forgiveness of interest on related party debt     49,808   49,808
Common stock issued for Directors fees     45,000   45,000
Common stock issued for Directors fees (in shares)   33,579      
Net loss       (8,294,146) (8,294,146)
Balance at Jun. 30, 2024 $ 9 $ 131 150,838,832 (139,374,895) 11,464,077
Balance (in shares) at Jun. 30, 2024 892,625 13,144,055      
Proceeds from sale of common stock in connection with equity financings net of issuance costs   $ 34 5,296,395   5,296,429
Proceeds from sale of common stock in connection with equity financings net of issuance costs (in shares)   3,351,096      
Series A preferred stock issued for employee stock compensation     60,722   60,722
Series A preferred stock issued for employee stock compensation (in shares) 13,092        
Common stock issued for consulting and legal services rendered   $ 1 115,499   115,500
Common stock issued for consulting and legal services rendered (in shares)   79,149      
Warrants issued to Scientific Advisory Board     679   679
Common stock issued for employee compensation     2,125   2,125
Common stock issued for employee compensation (in shares)   1,786      
Common stock issued for Directors fees     45,000   45,000
Common stock issued for Directors fees (in shares)   30,746      
Net loss       (9,466,966) (9,466,966)
Balance at Jun. 30, 2025 $ 9 $ 166 $ 156,359,252 $ (148,841,861) $ 7,517,566
Balance (in shares) at Jun. 30, 2025 905,717 16,606,832